IRCT20200407046981N44招募中未知
Comparative bioequivalence study of the Biperiden 4-mg extended-release tablets manufactured by Vana Darou Gostar Pharmaceutical Company versus Akineton® (Desma Company)
Vana Darou Gostar Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- Male
入选标准
- •Healthy male volunteers in the age range of 18-60 years old
- •The weight limit of each volunteer should be between 60 and 100 kg.
- •Body mass index should be between18-30
- •All volunteers must be non-smokers
- •They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics that will be assessed
- •Candidates who have consented to the consent form
排除标准
- •Known hypersensitivity or idiosyncratic reaction to Biperiden or any ingredients
- •Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg
- •Taking any medicine during two week before dosing.
- •Any effects of renal, hepatic, cardiac, pulmonary or gastrointestinal dysfunction
- •Any history of tuberculosis, seizures, asthma, diabetes, insanity or glaucoma
研究者
相似试验
尚未招募
不适用
Study of absorption and elimination rate of Pirfenidone 200-mg Tablets in comparison with Pirfenidone brand Tablets (Pirfenex®).Bioequivalence study.IRCT20200407046981N30Modava pharmaceutical company24
已完成
Unknown
Budesonide tablet bioequivalenceBioequivalence study in healthy volunteers.IRCT20130313012810N23Tasnim pharmaceutical Company24
尚未招募
不适用
Study of absorption and elimination rate of Domperidone suspension 1 mg/ml in comparison with Domperidone brand suspension (Motilium®).IRCT20200407046981N35ona Darou Pars Pharmaceutical Company24
尚未招募
不适用
Study of absorption and elimination rate of Domperidone suspension 1 mg/ml in comparison with Domperidone brand suspension (Motilium®).IRCT20200407046981N31Omid Behboud Pharmaceutical Co.24
已完成
不适用
Comparative bioequivalence study of the Nicorandil 20-mg tablets manufactured by Modava Pharmaceoutical companyIRCT20130313012810N6Modava Pharmaceutical Company24